PhaseV

PhaseVPhaseV
PhaseV

PhaseV

Develops a platform for adaptive clinical trial design and closed-loop execution.

Website
2023Active61
Rate
Advertise here

About

PhaseV provides AI/ML-driven solutions to optimize clinical development for biopharma sponsors and CROs. Their platform offers tools like Trial Optimizer, Response Optimizer, Portfolio Optimizer, and ClinOps Optimizer to improve trial design, decision-making, and operations, leading to faster, more efficient, and accurate clinical trials. PhaseV aims to increase trial success rates, enable sharper strategic decisions, and optimize the use of existing data.

Technology stack

detected 2026-06-23
CDN
Cloudflare
EmailGoogle Workspace
Stack
Webflow
Analytics
Google Analytics 4
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does PhaseV do?

PhaseV provides AI/ML-driven solutions to optimize clinical development for biopharma sponsors and CROs. Their platform offers tools like Trial Optimizer, Response Optimizer, Portfolio Optimizer, and ClinOps Optimizer to improve trial design, decision-making, and operations, leading to faster, more efficient, and accurate clinical trials. PhaseV aims to increase trial success rates, enable sharper strategic decisions, and optimize the use of existing data. (formerly PhaseV Trials.)

How much funding has PhaseV raised?

PhaseV has raised a total of $65M in funding. The most recent round on record is Series A.

Where is PhaseV headquartered?

PhaseV is headquartered in Tel Aviv, Israel.

When was PhaseV founded?

PhaseV was founded in 2023.

What industry does PhaseV operate in?

PhaseV operates in Life Sciences, Clinical Trials, Optimization, HealthTech, MedTech, Drug Discovery.

How many employees does PhaseV have?

PhaseV has approximately 61 people on record.